Clinical Trials Logo
  1. Home
  2. Brain Ischemia
  3. NCT05748587

Iron, Alpha-Synuclein, and Lymphocyte-activation Gene-3 in Ischemic Stroke

Brain Ischemia Clinical Trial

Official title:
Role of Iron, Alpha-Synuclein, and Lymphocyte-activation Gene-3 in the Pathophysiology of Ischemic Stroke in Human and Albino Rats

Clinical Trial Summary

This observational study aims to detect levels of iron, alpha-synuclein, and soluble lymphocyte activation gene 3 in acute ischemic stroke patients. And to see expressions of iron, alpha-synuclein, and lymphocyte activation gene 3 in the brain tissue of ischemic rats. The main questions it aims to answer are: - Is there an association between iron and alpha-synuclein accumulation in ischemic stroke? - Is there any change in soluble lymphocyte activation gene levels in ischemic stroke and if these levels are related to stroke severity and infarction size? . Can soluble lymphocyte activation gene levels be used as an early biomarker to diagnose ischemic stroke?

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05748587
Study type Observational
Source Aswan University Hospital
Contact Asmaa Abdelmageed Muhammed, Lecturer
Phone 01098548122
Email asmaa.ali@med.aswu.edu.eg
Status Recruiting
Phase
Start date April 1, 2023
Completion date April 1, 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT05131295 - Dapsone Use in Patients With Aneurysmal Subarachnoid Hemorrhage. Phase 3
Completed NCT01955642 - Evaluation of the Biological Response to Clopidogrel in Patients With Ischemic Stroke N/A
Completed NCT01915368 - Determining Optimal Post-Stroke Exercise (DOSE) N/A
Recruiting NCT01541163 - Heart and Ischemic STrOke Relationship studY N/A
Recruiting NCT06076122 - Salicornia for Neurovascular Health Improve N/A
Not yet recruiting NCT04386525 - Omega 3 and Ischemic Stroke; Fish Oil as an Option Phase 4
Recruiting NCT06270927 - A Feasibility Study for Randomization of Code Stroke Imaging Strategies
Completed NCT02912546 - Cerebral Perfusion Associated With Postural Changes: an ASL MR Perfusion Study N/A
Completed NCT02684825 - Detection of Silent Atrial Fibrillation aFter Ischemic StrOke N/A
Completed NCT05815836 - Precision Medicine in Stroke
Recruiting NCT01673932 - Safety and Feasibility Study of Umbilical Cord Blood Mononuclear Cells Transplant to Treat Ischemic Stroke Phase 1
Recruiting NCT01556802 - Use of Minocicline in Patients With Stroke Phase 1
Completed NCT02101606 - Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke Phase 2
Completed NCT00829361 - Stroke Telemedicine for Arizona Rural Residents Trial N/A
Terminated NCT00073372 - A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II) Phase 3
Recruiting NCT04908241 - Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL-RCT) N/A
Recruiting NCT04188132 - EEG Based BCI for Upper Limb Rehabilitation in Stroke N/A
Completed NCT01713491 - Pre-stroke Cognitive Status and Thrombolytic Therapy N/A
Completed NCT01443962 - The Effect of Positive End Expiratory Pressure (PEEP) During Laparoscopic Cholecystectomy N/A
Terminated NCT01059149 - Safety and Long-term Effectiveness of High Frequency Repetitive Transcranial Magnetic Stimulation of Stroke (RAICup) Phase 2